Shun Yu

1.2k total citations
21 papers, 557 citations indexed

About

Shun Yu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Shun Yu has authored 21 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Surgery. Recurrent topics in Shun Yu's work include Pancreatic and Hepatic Oncology Research (5 papers), Cancer Genomics and Diagnostics (4 papers) and Gastric Cancer Management and Outcomes (4 papers). Shun Yu is often cited by papers focused on Pancreatic and Hepatic Oncology Research (5 papers), Cancer Genomics and Diagnostics (4 papers) and Gastric Cancer Management and Outcomes (4 papers). Shun Yu collaborates with scholars based in United States, Israel and United Kingdom. Shun Yu's co-authors include Kim A. Reiss, Susan M. Domchek, Katherine L. Nathanson, Michelle N. Gong, Peter J. O’Dwyer, Ronac Mamtani, Mark Rosen, Evan S. Siegelman, Gregory L. Beatty and Max M. Wattenberg and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Critical Care Medicine.

In The Last Decade

Shun Yu

20 papers receiving 547 citations

Peers

Shun Yu

ONCOL

SURGE

PRM

EPIDE

Wigdan Al-Sukhni Canada

Cheryl Sickles United States

Assaf Moore Israel

K C Lakshmaiah India

Akin Inderson Netherlands

Barry R. De Young United States

Christopher D. Blosser United States

P. Clingan Australia

Chi‐Young Jeong South Korea

Shunrong Li China

Wigdan Al-Sukhni Canada

Shun Yu

437 ×1.4

ONCOL

139 ×0.9

268 ×2.0

SURGE

152 ×1.4

PRM

73 ×0.7

EPIDE

Citations per year, relative to Shun Yu Shun Yu (= 1×) peers Wigdan Al-Sukhni

Countries citing papers authored by Shun Yu

Since Specialization

Citations

This map shows the geographic impact of Shun Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shun Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shun Yu more than expected).

Fields of papers citing papers by Shun Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shun Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shun Yu. The network helps show where Shun Yu may publish in the future.

Co-authorship network of co-authors of Shun Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Shun Yu. A scholar is included among the top collaborators of Shun Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shun Yu. Shun Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Peng, Chengwei, Paul E. Oberstein, Charlene Thomas, et al.. (2024). Omission of 5-Fluorouracil Bolus From Multidrug Regimens for Advanced Gastrointestinal Cancers: A Multicenter Cohort Study. Journal of the National Comprehensive Cancer Network. 22(8). 521–527. 3 indexed citations

Margalit, Ofer, Shun Yu, Einat Shacham‐Shmueli, et al.. (2022). Benefit for single-agent adjuvant chemotherapy in elderly patients with locally advanced gastric adenocarcinoma. Journal of Cancer Research and Clinical Oncology. 148(7). 1703–1708.

Yu, Shun, Anh N. Le, Emily Feld, et al.. (2021). A Natural Language Processing–Assisted Extraction System for Gleason Scores: Development and Usability Study. JMIR Cancer. 7(3). e27970–e27970. 7 indexed citations

Harel, Michal, Shun Yu, Ettai Markovits, et al.. (2021). Clinical Proteomics of Metastatic Melanoma Reveals Profiles of Organ Specificity and Treatment Resistance. Clinical Cancer Research. 27(7). 2074–2086. 14 indexed citations

Yu, Shun, Ronac Mamtani, Mark H. O’Hara, et al.. (2021). Comparative Effectiveness of Total Neoadjuvant Therapy Versus Standard Adjuvant Chemotherapy for Locally Advanced Rectal Cancer. Clinical Colorectal Cancer. 20(2). 121–129. 7 indexed citations

Davoudi, Anahita, et al.. (2021). Lexicon Development for COVID-19-related Concepts Using Open-source Word Embedding Sources: An Intrinsic and Extrinsic Evaluation. JMIR Medical Informatics. 9(2). e21679–e21679. 1 indexed citations

Davoudi, Anahita, et al.. (2020). Annotation and extraction of age and temporally-related events from clinical histories. BMC Medical Informatics and Decision Making. 20(S11). 338–338. 8 indexed citations

Hannan, Zain M., Shun Yu, Susan M. Domchek, Ronac Mamtani, & Kim A. Reiss. (2020). Clinical Characteristics of Patients With Pancreatic Cancer and Pathogenic ATM Alterations. JNCI Cancer Spectrum. 5(2). 9 indexed citations

Wattenberg, Max M., Shun Yu, Peter J. O’Dwyer, et al.. (2019). Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation. British Journal of Cancer. 122(3). 333–339. 130 indexed citations

10.

Yu, Shun, Parul Agarwal, Ronac Mamtani, et al.. (2019). Retrospective Survival Analysis of Patients With Resected Pancreatic Ductal Adenocarcinoma and a Germline BRCA or PALB2 Mutation. JCO Precision Oncology. 3(3). 1–11. 25 indexed citations

11.

Geynisman, Daniel M., Robert A. Somer, Arjun Vasant Balar, et al.. (2019). Efficacy of Split Schedule Versus Conventional Schedule Neoadjuvant Cisplatin-Based Chemotherapy for Muscle-Invasive Bladder Cancer. The Oncologist. 24(5). 688–690. 15 indexed citations

12.

Reiss, Kim A., Shun Yu, Renae Judy, et al.. (2018). Retrospective Survival Analysis of Patients With Advanced Pancreatic Ductal Adenocarcinoma and Germline BRCA or PALB2 Mutations. JCO Precision Oncology. 2(2). 1–9. 43 indexed citations

13.

Reiss, Kim A., Shun Yu, Ronac Mamtani, et al.. (2017). Starting Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study. Journal of Clinical Oncology. 35(31). 3575–3581. 74 indexed citations

14.

Kaplan, David E., Shun Yu, Tamar H. Taddei, et al.. (2017). Up-titration of sorafenib for hepatocellular carcinoma: Impact on duration of exposure and cost.. Journal of Clinical Oncology. 35(4_suppl). 385–385. 3 indexed citations

15.

Sclafani, Francesco, Gina Brown, David Cunningham, et al.. (2016). PAN-EX: a pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradiotherapy in MRI-defined, locally advanced rectal cancer. Annals of Oncology. 27(8). 1557–1565. 54 indexed citations

16.

Yu, Shun, et al.. (2016). Illness Severity and Comorbidities Are Associated With Limitations in Computed Tomography Pulmonary Angiography. Journal of Thoracic Imaging. 31(5). W60–W61. 5 indexed citations

17.

Yu, Shun, Sharon Leung, Moonseong Heo, et al.. (2014). Comparison of risk prediction scoring systems for ward patients: a retrospective nested case-control study. Critical Care. 18(3). R132–R132. 45 indexed citations

18.

Chand, Manish, Shun Yu, R I Swift, & Gina Brown. (2013). Mucinous carcinoma of the rectum: a distinct clinicopathological entity. Techniques in Coloproctology. 18(4). 335–344. 32 indexed citations

19.

Yu, Shun, David C. Christiani, Bruce Thompson, Ednan K. Bajwa, & Michelle N. Gong. (2013). Role of Diabetes in the Development of Acute Respiratory Distress Syndrome*. Critical Care Medicine. 41(12). 2720–2732. 50 indexed citations

20.

Hao, X., Peter Wang, Kexin Chen, et al.. (2003). Twenty-year trends of primary liver cancer incidence rates in an urban Chinese population. European Journal of Cancer Prevention. 12(4). 273–279. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact